Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Aslan reports promising clinical data on ASLAN-004 in atopic dermatitis

March 1, 2021

Celldex plans clinical study of CDX-0159 in prurigo nodularis

Feb. 23, 2021

Phase II study of Thykamine in atopic dermatitis meets its primary endpoint

Feb. 19, 2021

Phase II study of KHK-4083 in atopic dermatitis meets primary endpoint

Feb. 19, 2021

vTv initiates phase I study of PDE4 inhibitor HPP-737 for psoriasis

Feb. 18, 2021

Phase III studies show superiority of topical tirbanibulin to vehicle in actinic keratosis

Feb. 15, 2021

InflaRx presents data from phase IIb SHINE study of vilobelimab

Feb. 12, 2021

BenevolentAI begins first-in-human trial of BEN-2293 for atopic dermatitis

Feb. 12, 2021

Morphine itch comes from neurons, not mast cells

Feb. 9, 2021

China's NMPA accepts Kintor's IND for topical AR degrader GT-20029

Feb. 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...